From the Wires
Aviir, Inc.'s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Women's Expo
Heart disease, the leading killer of women in the U.S., is also a major cause of disability and bankruptcy, according to Dr. Harrington
By: PR Newswire
Nov. 4, 2012 03:28 PM
IRVINE, Calif., Nov. 4, 2012 /PRNewswire/ -- Dr. Douglas Harrington, CEO of Aviir, Inc., joined a host of influential companies and experts at the Los Angeles Ultimate Women's Expo on Saturday, October 27 to discuss America's leading threat to women: Heart Disease. Dr. Harrington's lecture "Everything You Ever Wanted to Know About Heart Disease But Were Afraid to Ask" provided a higher level of insight into the disease and how women can empower themselves, improving their cardiovascular health. The speaking session began at 12:30 PM, at the Los Angeles Convention Center and was sponsored by GuardaHeart Foundation.
As CEO of Aviir, Inc., Dr. Harrington brings more than 25 years of experience in the commercialization of health care technology. Aviir, Inc. is an Irvine-based biotechnology company that develops innovative diagnostic and laboratory tests. Dr. Harrington's personal mission is to offer clarity to heart disease through reliable assessments and prevention.
The Los Angeles Ultimate Women's Expo sought out some of the best seminar speakers around the world to participate in their event, which is held in several cities across the country.
GuardaHeart sponsors heart risk assessments through an on-going collaboration with Aviir. Far too many lives continue to be needlessly lost to heart disease, while many more are burdened with the medical debt caused by surviving a heart attack.
"Heart Disease remains the leading cause of death in the US, claiming almost 600,000 lives each year, yet many are unaware that 80% of heart disease is preventable through lifestyle modification," said Dr. Harrington. Through GuardaHeart's movement "Pledge to SaveThe1" individuals are empowered and equipped to make these critical lifestyle modifications.
Dr. Harrington also discussed an innovative blood test, developed through an Aviir/Stanford University cardiology collaboration, which identifies an individuals' cardiac risk in a five-year timeframe. "This timeframe allows preventive measures to be implemented," continued Dr. Harrington. "Our mission is to improve healthcare and encourage timely preventive strategies by providing this unique medical information."
About Aviir, Inc.
About Los Angeles Ultimate Women's Expo
For media inquiries, please contact: Dina Scaglione (949) 398-6320 email@example.com
For Interviews at the Expo please contact:
SOURCE Aviir, Inc.
SOA World Latest Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week